Professional paper

Proposal for biologic drugs therapy in rheumatoid arthritis

Božidar Ćurković ; Croatian Society for Rheumatology, Croatian Medical Association, Zagreb, Croatia
Đurđica Babić-Naglić ; Croatian Society for Rheumatology, Croatian Medical Association, Zagreb, Croatia
Jadranka Morović-Vergles ; Croatian Society for Rheumatology, Croatian Medical Association, Zagreb, Croatia
Branimir Anić ; Croatian Society for Rheumatology, Croatian Medical Association, Zagreb, Croatia
Simeon Grazio ; Croatian Society for Rheumatology, Croatian Medical Association, Zagreb, Croatia
Dušanka Martinović Kaliterna ; Croatian Society for Rheumatology, Croatian Medical Association, Zagreb, Croatia
Marino Hanih ; Croatian Society for Rheumatology, Croatian Medical Association, Zagreb, Croatia
Srđan Novak ; Croatian Society for Rheumatology, Croatian Medical Association, Zagreb, Croatia

Abstract

Rheumatoid arthritis is a chronic, inflammatory disease with the prevalence about 1 %. Rheumatoid arthritis is characterized with synovitis, often evolve erosions of the joints, pain and functional deficit. Etiology is unknown, but the development of such autoimmune disease is due to genetic and environmental factors. Most of the patients with diagnosis of rheumatoid arthritis use nonbiologic disease modifying antirheumatic drugs. Advances in the undersstanding of the disease process have led to the development of biological agents to treat rheumatoid arthritis. With the use of biologic agents we wish to evolve the goal of therapy from that of symptomatiic relief to clinical remission. Biologic drugs have documented, fast and continuous efficacy with generaly well accepted safety profile. On behalf of Croatian Society for Rheumatology we propose recommendations for the biologic therapy in rheumatoid arthritis.

Keywords

rheumatoid arthritis; biologic drugs; recommendations

Hrčak ID:

124784

URI

https://hrcak.srce.hr/124784

Publication date:

1.7.2010.

Article data in other languages: croatian

Visits: 1.716 *